dr. L.F.D. (Lize) van Vulpen

Assistant Professor - medical
dr. L.F.D. (Lize) van Vulpen
  • Hematology/Van Creveldclinic

Research Output (29)

Treatment of acquired hemophilia A (AHA), a balancing act: results from a 27-year Dutch cohort study:results from a 27-year Dutch cohort study

Schep Sarah J, van Dijk Wobke E M, Beckers Erik A M, Meijer Karina, Coppens Michiel, Eikenboom Jeroen, Leebeek Frank W G, van Vulpen Lize F D, Fischer Kathelijn F, Schutgens Roger E G, 10 okt 2020, In: American Journal of Hematology. 96 , p. 51-59 9 p.

Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc

Traets Marissa J M, Fischer Kathelijn, Uitslager Nanda, van der Valk Paul R, Kremer Hovinga Idske C L, van Vulpen Lize F D, Schutgens Roger E G okt 2020, In: TH open : companion journal to thrombosis and haemostasis. 4 , p. e362-e364

Diagnostiek bij een vermoedelijke stollingsstoornis

van Vulpen Lize F.D., Wichers Iris M., Urbanus Rolf T., van Galen Karin P.M. 1 jan 2020, In: Nederlands Tijdschrift voor Geneeskunde. 164 7 p.

Proteoglycan synthesis rate as a novel method to measure blood-induced cartilage degeneration in non-haemophilic and haemophilic rats

Pulles Astrid E., Vøls Kåre K., Christensen Kristine R., Coeleveld Katja, Hansen Axel K., van Vulpen Lize F.D., Petersen Maj, Mastbergen Simon C., Roepstorff Kirstine, Schutgens Roger E.G., Kjelgaard-Hansen Mads, Lafeber Floris P.J.G. 1 jan 2020, In: Haemophilia. 26 , p. e88-e96 9 p.

An update on the ‘danger theory’ in inhibitor development in hemophilia A

Schep Sarah J, Boes Marianne L, Schutgens Roger E G, van Vulpen Lize F D 5 apr 2019, In: Expert Review of Hematology. 12 , p. 335-344 10 p.

Models of arthropathy:what can we learn from them to improve patient care?

Pulles Astrid E, Lafeber Floris P J G, van Vulpen Lize F D 19 sep 2018, In: Rheumatology (Oxford, England). 58 , p. 565-566 2 p.

Gewrichtsschade ten gevolge van hemofilie

van Vulpen LFD, Pulles AE, Lafeber FPJG, Mastbergen SC, Schutgens REG sep 2018, In: Nederlands Tijdschrift voor Hematologie. 15 , p. 257 264 p.

Continuous infusion of extended half-life factor VIII (efmoroctocog alpha) for surgery in severe haemophilia A

Kremer Hovinga I. C.L., Schutgens R. E.G., van der Valk P. R., van Vulpen L. F.D., Mauser-Bunschoten E. P., Fischer K. 1 jul 2018, In: Haemophilia. 24 , p. e280-e283

The combination of urinary CTX-II and serum CS-846:Promising biochemical markers to predict radiographic progression of haemophilic arthropathy—An exploratory study

Pulles A. E., Mastbergen S. C., Foppen W., Schutgens R. E.G., Lafeber F. P.J.G., van Vulpen L. F.D. jun 2018, In: Haemophilia. 24 , p. e278-e280

Joint disease in haemophilia:Pathophysiology, pain and imaging

van Vulpen L. F.D., Holstein K., Martinoli C. 1 mei 2018, In: Haemophilia. 24 , p. 44-49 6 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.